Summary of GAO's Findings on the Safety and Efficacy of the Anthrax Vaccine

Abstract

Concerns have been raised about the Department of Defense's (DOD) anthrax immunization program since DOD began vaccinating its 2.4 million active duty and reserve members in 1998. At your request, we are providing you with information we have previously reported concerning (1) the need for a six-shot regimen and annual booster shots, (2) the long- and short-term safety of the vaccine, (3) the efficacy of the vaccine and (4) the extent to which problems the Food and Drug Administration (FDA) found in the vaccine production facility in Michigan could compromise the safety, efficacy, and quality of the vaccine. We are also providing for you the three testimonies that are the source of the information we are providing you today.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Nov 04, 1999
Accession Number
AD1169418

Entities

People

  • Kwai-cheung Chan
  • Sushil Sharma

Organizations

  • United States Government Accountability Office

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Accounting
  • Active Duty
  • Animals
  • Department Of Defense
  • Electronic Mail
  • Health
  • Health Care
  • Health Services
  • Immunization
  • Medical Personnel
  • Michigan
  • Military Personnel
  • National Security
  • Passive Surveillance
  • Production
  • Public Health
  • Rodents
  • Side Effects
  • United States
  • Vaccines
  • World Wide Web

Readers

  • Defense Acquisition Program Management
  • Immunology
  • Oncology

Technology Areas

  • Biotechnology